Assay buffer, compositions containing the same, and methods of using the same
AssigneeMeso Scale Technologies, LLC.
InventorsMichael Tsionsky, Eli N. Glezer, Selen Altunata, George Sigal, Jonathan K. Leland, Mark A. Billadeau, Svetlana Leytner, Mark Martin, Larry Helms
Life of this patent
Estimating the term…
Abstract
The invention relates to improved electrochemiluminescence assay methods for phosphorylated peptides or proteins employing phospho-specific antibodies and buffer compositions that are substantially free of inorganic phosphate.
Claims17
A method of conducting an electrochemiluminescence (ECL) assay for detecting a phosphorylated peptide or protein or phosphorylation of a peptide or protein in a sample, said method comprising:
- (a) contacting an assay electrode with said sample and a phospho-specific antibody comprising an ECL label, said assay electrode including a binding domain comprising a binding reagent immobilized thereto, wherein said binding reagent is specific for said phosphorylated peptide or protein, said contacting step thereby forming a complex immobilized to said electrode, said complex comprising said binding reagent, said phosphorylated peptide or protein, and said phospho-specific antibody;
- (b) contacting said electrode with an ECL assay buffer, wherein said ECL assay buffer has a concentration of less than 5 mM inorganic phosphate and comprises an ECL coreactant, glycylglycine and an organic co-solvent;
- (c) applying electrochemical energy to said electrode under conditions suitable to induce ECL labels on said antibody to emit electrochemiluminescence;
- and
- (d) measuring emitted electrochemiluminescence;
- wherein a phosphorylated peptide or protein, or phosphorylation of a peptide or protein, is detected by an increase in electrochemiluminescence.
A method of measuring a binding interaction between a phospho-peptide or protein and a phospho-specific antibody, said method comprising:
- (a) combining said phospho-peptide or protein and said phospho-specific antibody in a pH buffer, wherein said pH buffer has a concentration of less than 5 mM inorganic phosphate and comprises glycylglycine, wherein said combining step is conducted under conditions suitable to form said binding interaction;
- and
- (b) detecting said binding interaction.
Dependencies are inferred from the claim text.